Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development

Jayakrishna Ambati(University of Virginia), Bradley D. Gelfand(University of Virginia)
Nature Communications
September 23, 2020
Cited by 61


Related Papers